Sandra Davidge, PhD, FRSC, FCAHS

Area of Study / Keywords

---

About

Dr. Sandra Davidge is a Distinguished University Professor and the Executive Director of the Women and Children’s Health Research Institute (WCHRI). She is a Professor in the Department of Obstetrics & Gynecology and Adjunct Professor in the Department of Physiology at the University of Alberta. As a leader in pregnancy research, Dr. Davidge is a Fellow of the Royal Society of Canada (FRSC) and the Canadian Academy of Health Sciences (CAHS). She has published over 280 scientific articles on pioneering studies that are focused on understanding the causes on pregnancy complications, such as preeclampsia and intrauterine growth restriction, in order to develop new therapies to improve pregnancy outcomes.

Place of Graduation: University of Vermont, 1993

Post-doctoral Training: Magee Womens Research Institute; University of Pittsburgh, 1993-1996

Research Interests: Pregnancy Complications, Preeclampsia, Advanced Maternal Age, Developmental Origins of Cardiovascular Disease, Cardiovascular Physiology

Distinction: Former 2-term Canada Research Chair Tier 1 in Maternal and Perinatal Cardiovascular Health, Government of Canada, 2007-2021

---

Research

Research Focus & Overview

The Davidge laboratory studies cardiovascular physiology with a specific interest in the area of women’s, maternal and perinatal cardiovascular health. We investigate potential mediators for vascular endothelial cell dysfunction in both and deficiency as well as in the pregnancy complication, preeclampsia. Moreover, we combine our expertise in and pregnancy complications to study the cardiovascular effects for offspring born from an adverse intrauterine environment (also known as developmental origins of disease).

Preeclampsia

Studies include understanding mechanisms normal cardiovascular adaptations of pregnancy as well as mechanisms for impaired vascular responses in women with preeclampsia, a pregnancy disorder by hypertension and proteinuria. This work addresses the regulation of vascular tone by factors such as nitric oxide and matrix metalloproteinase. Moreover, we study the effect of oxidative stress on endothelial cell function as a potential mechanism for vascular dysfunction in women with preeclampsia.

Effects of Maternal on Vascular Function

Another area of research for this laboratory is studying the impact of on the vasculature with a specific interest the action of sex steroids on vascular function.  Moreover,  the age at which women deliver their first child has increased steadily. In Canada, births occurring among women aged 35 years and older account for over 18% of total live births. Childbirth at an advanced maternal age (=35 years) has a myriad of clinical ramifications, including increased risk of preeclampsia and intrauterine growth restriction. Children born from a suboptimal intrauterine environment are at a greater risk of cardiovascular morbidities later in life. Our laboratory is studying the consequences of maternal on vascular function with interests in both maternal and offspring health.

Fetal Programming of Cardiovascular Disease

Complications in pregnancy may also influence cardiovascular health in the offspring. Numerous epidemiological studies have determined an association between a poor uterine environment (usually reflected by low birth weight) and the occurrence of cardiovascular diseases later in life. It is likely that adaptive responses to fetal/neonatal environmental stresses lead to permanent changes that negatively influence metabolic and cardiovascular health in adult life. However, the mechanisms underlying these changes are not known. Our laboratory assesses mechanisms for altered cardiovascular responses in pregnancies from an adverse maternal environment as well as assessing the offspring from these pregnancies in various life stages (fetal, neonatal, young and aged adults).

Trainees

The Davidge laboratory is committed to the training of undergraduate and graduate students as well as post-doctoral fellows with an average of 8-10 trainees in the laboratory.

Funding Support

This research is supported by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, Alberta Innovates, Canada Foundation for Innovation;  along with the Stollery Children’s Health Foundation and the Alberta Women’s Health Foundation through the Women and Children’s Health Research Institute.  

Techniques
� Vascular function studies using myography are conducted on isolated small arteries from our various animal models. 
� Analysis of the expression of various enzymes and receptors using Western blot and Immunohistochemistry techniques. 
� Cell cultures of endothelial and smooth muscle cells to assess cellular mechanisms. 

Pasha M, Kirschenman R, Wooldridge A, Spaans F, Cooke CLM, Davidge ST

Antioxidants. 2022 June; doi.org/10.3390/antiox11071275

---

J Agric Food Chem. 2022 June; 70 (21):6397-6406 doi: 10.1021/acs.jafc.1c07161

---

Wang B, Wu HH, Abuetabh Y, Leng S, DAVIDGE ST, Flores ER, Eisenstat DD, Leng RP

Cell Death and Disease. 2022 April; 13 (4):397 doi: 10.1038/s41419-022-04854-1

---

Fan H, Liao W, Spaans F, Pasha M, DAVIDGE ST, Wu J

Journal of Food Science. 2022 March; 87 doi: 10.1111/1750-3841.16077

---

Wooldridge AL, Hula N, Kirschenman R, Spaan F, Cooke CLM, DAVIDGE ST.

Journal of Developmental Origins of Health and Disease. 2022 March; doi:10.1017/ S2040174422000216

---

Hula N, Vu J, Quon A, Kirschenman R, Spaans F, Liu R, Cooke C-LM, DAVIDGE ST

American Journal of Physiology, Heart and Circulatory Physiology. 2022 March; 322 doi: 10.1152/ajpheart.00636.2021

---

Goulopoulou S., De Groot C., Taylor R.N., Davidge S.T.

Chesley’s Hypertensive Disorders in Pregnancy, Fifth Edition. 2022 January; 10.1016/B978-0-12-818417-2.00006-3

---

Vatish M., Redman C.W.G., Davidge S.T.

Chesley’s Hypertensive Disorders in Pregnancy. 2022 January; 10.1016/B978-0-12-818417-2.00019-1

---

Conrad K.P., Taylor R.N., Davidge S.T., Staff A.C., Roberts J.M., Lindheimer M.D.

Chesley's Hypertensive Disorders in Pregnancy- 5th Edition. 2022 January; 10.1016/B978-0-12-818417-2.00022-1

---

Dechend R., Lamarca B., Davidge S.T.

Chesley’s Hypertensive Disorders in Pregnancy. 2022 January; 10.1016/B978-0-12-818417-2.00010-5

---

Staff A.C., Figueiro-Filho E., Davidge S.T.

Chesley's Hypertensive Disorders in Pregnancy- 5th Edition. 2022 January; 10.1016/B978-0-12-818417-2.00014-2

---

Taylor R.N., Conrad K.P., Davidge S.T., Staff A.C., Roberts J.M.

Chesley’s Hypertensive Disorders in Pregnancy. 2022 January; 10.1016/B978-0-12-818417-2.01001-0

---

Jeyabalan A., Hubel C.A., Davidge S.T.

Chesley's Hypertensive Disorders in Pregnancy- 5th Edition. 2022 January; 10.1016/B978-0-12-818417-2.00017-8

---

Sáez T., Wiley C., Quon A., Spaans F., Davidge S.T.

Pregnancy Hypertension. 2021 December; 26 10.1016/j.preghy.2021.09.007

---

Nerenberg K.A., Cooke C.L., Smith G.N., Davidge S.T.

Canadian Journal of Cardiology. 2021 December; 37 (12):2056-2066 10.1016/j.cjca.2021.08.007

---

Tewari S., Margalef P.T., Kareem A., Abdul-Hussein A., White M., Wazana A., Davidge S.T., Delrieux C., Connor K.L.

Journal of Personalized Medicine. 2021 November; 11 10.3390/jpm11111064

---

Pasha M., Wooldridge A.L., Kirschenman R., Spaans F., Davidge S.T., Cooke C.L.M.

Frontiers in Physiology. 2021 July; 10.3389/fphys.2021.718568

---

Abdul-Hussein A., Kareem A., Tewari S., Bergeron J., Briollais L., Challis J.R.G., Davidge S.T., Delrieux C., Fortier I., Goldowitz D., Nepomnaschy P., Wazana A., Connor K.L.

Mol Aspects Med. 2021 July; 87:100986 doi: 10.1016/j.mam.2021.100986

---

Do V., Eckersley L., Lin L., Davidge S.T., Stickland M.K., Ojala T., Serrano-Lomelin J., Hornberger L.K.

CJC Open. 2021 March; 3 (3):345-353 10.1016/j.cjco.2020.10.020

---

Ganguly E., Kirschenman R., Spaans F., Holody C.D., Phillips T.E.J., Case C.P., Cooke C.L.M., Murphy M.P., Lemieux H., Davidge S.T.

The FASEB Journal. 2021 February; 35 (2) 10.1096/fj.202002193R

---

Kumaran K., Krishnaveni G.V., Suryanarayana K.G., Prasad M.P., Belavendra A., Atkinson S., Balasubramaniam R., Bandsma R.H.J., Bhutta Z.A., Chandak G.R., Comelli E.M., Davidge S.T., Dennis C.L., Hammond G.L., Jha P., Joseph K.S., Joshi S.R., Krishna M., Lee K., Lye S., McGowan P., Nepomnaschy P., Padvetnaya V., Pyne S., Sachdev H.S., Sahariah S.A., Singhal N., Trasler J., Yajnik C.S., Baird J., Barker M., Martin M.C., Husain N., Sellen D., Fall C.H.D., Shah P.S., Matthews S.G.

BMJ Open. 2021 February; 11 (2) 10.1136/bmjopen-2020-045862

---

Hula N., Spaans F., Vu J., Quon A., Kirschenman R., Cooke C.L.M., Phillips T.J., Case C.P., Davidge S.T.

PHARMACOLOGICAL RESEARCH. 2021 January; 165 (105461) 10.1016/j.phrs.2021.105461

---

Reyes L.M., Usselman C.W., Khurana R., Chari R.S., Stickland M.K., Davidge S.T., Julian C.G., Steinback C.D., Davenport M.H.

JOURNAL OF APPLIED PHYSIOLOGY. 2021 January; 130 (1):139-148 10.1152/JAPPLPHYSIOL.00646.2020

---

Ganguly E., Hula N., Spaans F., Cooke C.L.M., Davidge S.T.

PHARMACOLOGICAL RESEARCH. 2020 November; 157 10.1016/j.phrs.2020.104836

---

View additional publications